Document Type : Original Article


Department of Venomous Animal, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran


Introduction and Aim: Alginate nanoparticles have been used in novel drug delivery systems due to marvelous features including biocompatibility, biodegradable, mucoadhesive, and non-toxic. At present various types of adjuvants are used against snake venom, as a solution, suspension, or emulsion systems, which are used in different centers. The purpose of this study is to design a novel type of antigen delivery system as an adjuvant from alginate nanoparticles.
Methods: Alginate nanoparticles were prepared based on the ionic gelation process. The nanoparticles' particle size, morphology, zeta potential, in vitro release behavior, and structure of nanoparticles contained venom were analyzed by SEM, DLS, and FT-IR spectroscopy. Cell viability of SW-480 cells was measured using an MTT assay.
Results: The particles were spherical. The optimum particles size of alginate and venom-loaded nanoparticles were 118 and 169 nm, respectively. Viability significantly decreased in cells exposed to upper 20 µg/ml o (P<0.05).
Conclusion: Our results suggested that alginate nanoparticles, which were prepared in our study possibly, could be used as an alternative for traditional adjuvant systems.


Main Subjects

Adamian, M., Hekmat, A. and Hajebrahimi, Z. 2021. The impacts of simulated microgravity on the cell viability and claudin-1 and claudin-3 expression of mcf-7 breast cancer cells. Journal of Sciences, Islamic Republic of Iran, 32(2): 105-114.
Ahmad, Z., Pandey, R., Sharma, S. and Khuller, G. 2006. Alginate nanoparticles as antituberculosis drug carriers: Formulation development, pharmacokinetics and therapeutic potential. Indian journal of chest diseases and allied sciences, 48(3): 171.
Bagre, A.P., Jain, K. and Jain, N.K. 2013. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment. International journal of pharmaceutics, 456(1): 31-40.
Barbadilla Martín, M. 2017. Utilización de quitosano en sistemas gastrorretentivos.
Biswas, S., Chattopadhyay, M., Sen, K.K. and Saha, M.K. 2015. Development and characterization of alginate coated low molecular weight chitosan nanoparticles as new carriers for oral vaccine delivery in mice. Carbohydrate polymers, 121: 403-410.
Blandino, A., Macias, M. and Cantero, D. 1999. Formation of calcium alginate gel capsules: Influence of sodium alginate and cacl2 concentration on gelation kinetics. Journal of bioscience and bioengineering, 88(6): 686-689.
Bon, C. 1996. The serum-therapie was discovered 100 years ago. Toxicon, 2(34): 142-143.
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G. and Junginger, H.E. 2008. Immune response by nasal delivery of hepatitis b surface antigen and codelivery of a cpg odn in alginate coated chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 69(2): 405-416.
Borumand, M.R. 2013. Preparation and characterization of sodium alginate nanoparticles containing icd-85 (venom derived peptides). International journal of innovation and applied studies, 4(3): 534-542.
Fletcher, J.E., Jiang, M.-S., Gong, Q.-H., Yudkowsky, M.L. and Wieland, S.J. 1991. Effects of a cardiotoxin from naja naja kaouthia venom on skeletal muscle: Involvement of calcium-induced calcium release, sodium ion currents and phospholipases a2 and c. Toxicon, 29(12): 1489-1500.
Freire-Maia, L., Campos, J. and Amaral, C. 1994. Approaches to the treatment of scorpion envenoming. Toxicon, 32(9): 1009-1014.
Mohammadpourdounighi, N., Behfar, A., Ezabadi, A., Zolfagharian, H. and Heydari, M. 2010. Preparation of chitosan nanoparticles containing naja naja oxiana snake venom. Nanomedicine: Nanotechnology, Biology and Medicine, 6(1): 137-143.
Nafian, F., Nafian, S. and Kamali Doust Azad, B. 2020. Regulatory and biosafety challenges for vaccines. Iranian Journal of Medical Microbiology, 14(1): 17-29.
poMohammadur Dounighi, N., Mehrabi, M., Avadi, M., Zolfagharian, H. and Rezayat, M. 2015. Preparation, characterization and stability investigation of chitosan nanoparticles loaded with the echis carinatus snake venom as a novel delivery system. Archives of Razi Institute, 70(4): 269-277.
Sarei, F., Dounighi, N.M., Zolfagharian, H., Khaki, P. and Bidhendi, S.M. 2013. Alginate nanoparticles as a promising adjuvant and vaccine delivery system. Indian Journal of Pharmaceutical Sciences, 75(4): 442.
Sonavane, G.S. and Devarajan, P.V. 2007. Preparation of alginate nanoparticles using eudragit e100 as a new complexing agent: Development, in-vitro, and in-vivo evaluation. Journal of biomedical nanotechnology, 3(2): 160-169.
Tokumitsu, H., Ichikawa, H. and Fukumori, Y. 1999. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: Preparation by novel emulsion-droplet coalescence technique and characterization. Pharmaceutical research, 16(12): 1830-1835.
Van der Lubben, I., Verhoef, J., Borchard, G. and Junginger, H. 2001. Chitosan for mucosal vaccination. Advanced drug delivery reviews, 52(2): 139-144.
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J.L.V. and Alonso, M.J. 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. European Journal of pharmaceutics and biopharmaceutics, 57(1): 123-131.
Wang, R., Cai, J., Huang, Y., Xu, D., Sang, H. and Yan, G. 2009. Novel recombinant fibrinogenase of agkistrodon acutus venom protects against lps-induced dic. Thrombosis research, 123(6): 919-924.